Drug interactions
Dichlorphenamide + Panitumumab
Severity: Moderate
Dichlorphenamide and Panitumumab: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dichlorphenamide lowers serum potassium, and panitumumab commonly causes hypomagnesemia and may cause hypokalemia. Together they may increase the risk of significant electrolyte depletion.
What this interaction means in plain words
Dichlorphenamide and Panitumumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dichlorphenamide belongs to Miscellaneous; Panitumumab belongs to Oncology.
Why it happens
Additive hypokalemia, with panitumumab causing renal magnesium wasting through EGFR inhibition.
What to do
Monitor potassium and magnesium before and during treatment. Replace deficits promptly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Panitumumab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dichlorphenamide
Frequently asked questions
Can I take Dichlorphenamide with Panitumumab?
MediHelp rates the interaction as moderate. Dichlorphenamide and Panitumumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dichlorphenamide lowers serum potassium, and panitumumab commonly causes hypomagnesemia and may cause hypokalemia. Together they may increase the risk of significant electrolyte depletion.
How serious is the interaction between Dichlorphenamide and Panitumumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor potassium and magnesium before and during treatment. Replace deficits promptly.
What other medicines interact with Dichlorphenamide?
MediHelp also lists interactions of Dichlorphenamide with, for example, Acetazolamide, Acetylsalicylic acid, Ammonium chloride. The full list is on the Dichlorphenamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
